My Intelligent Machines

[On Demand]
By harnessing patient and disease data, multi-omics and scientific literature, the fast-growing, AI company My Intelligent Machines (MIMs) is breaking new ground with software solutions that accelerate the identification of drug targets and biomarkers in Biopharm and Agtech.

With its solutions, MIMs is challenging the current discovery model with an augmented intelligence software that layers the drug manufacturer’s own proprietary patient data on MIMs’ knowledge-base from a vast library of structured and unstructured public data, to create a customized and turnkey solution.

MIMs uses a software-as-a-service (SaaS) business model, allowing the software to be adapted to the client’s needs on a fee-for-service basis and a subscription fee granting access to the software on a secure web interface.

My Intelligent Machines